Request Demo
Last update 04 Jan 2026
ASKG-915
Last update 04 Jan 2026
Overview
Basic Info
Drug Type Fusion protein |
Synonyms ASKG 915, ASKG915 |
Target |
Action modulators, inhibitors |
Mechanism Interleukin-15 receptors modulators(Interleukin-15 receptors modulators), PD-1 inhibitors(Programmed cell death protein 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with ASKG-915NCT05867420
A Phase 1 Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ASKG915 as a Single Agent in Patients With Selected Advanced Solid Tumors.
100 Clinical Results associated with ASKG-915
Login to view more data
100 Translational Medicine associated with ASKG-915
Login to view more data
100 Patents (Medical) associated with ASKG-915
Login to view more data
100 Deals associated with ASKG-915
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced cancer | Phase 1 | United States | 02 Aug 2023 | |
| Advanced Malignant Solid Neoplasm | Phase 1 | United States | 02 Aug 2023 | |
| Solid tumor | Phase 1 | United States | - | |
| Metastatic Solid Tumor | IND Approval | China | 08 Apr 2025 | |
| Unresectable Solid Neoplasm | IND Approval | China | 08 Apr 2025 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 1/2 | 46 | nkaquyderl(qkhcxhncbl) = lilaepeekl vfiwijwwba (vjnbmztauq ) View more | Positive | 05 Nov 2025 | |||
(In 3rd line and above MSS CRC subgroup at the mid dose level or above) | gcmdvnevsp(oujtkgbfgp) = dfznsuttyk swearcjyck (ikdjjmydml ) |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free